VOCAL-EXT: Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus Nephritis (clinicaltrials.gov) - Feb 11, 2026 - P3 | N=4 | Terminated | Sponsor: Aurinia Pharmaceuticals Inc. | N=40 ➔ 4 | Trial completion date: Jun 2029 ➔ Jul 2025 | Enrolling by invitation ➔ Terminated | Trial primary completion date: Dec 2028 ➔ Jul 2025; DSMB recommendation
Enrollment change • Trial completion date • Trial primary completion date • Trial termination • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Pediatrics
|